Results 31 to 40 of about 599,967 (286)

Treatment of Granulomatosis with Polyangiitis and Microscopic Polyangiitis [PDF]

American Society of Nephrology. Clinical Journal, 2020
Granulomatosis with polyangiitis (GPA) and microscopic polyangiitis (MPA) are two major clinical entities recognized among ANCA-associated vasculitides.
Vladimı́r Tesař, Zdenka Hrušková
openalex   +2 more sources

Eosinophilic Granulomatosis With Polyangiitis Presenting With Oral Granuloma as the Initial Symptom: A Case Report

Frontiers in Medicine, 2022
Antineutrophil cytoplasmic antibody associated vasculitis includes granulomatosis with polyangiitis, eosinophilic granulomatosis with polyangiitis (EGPA), and microscopic polyangiitis.
Lirong Lin, Rongjie Yu, Luquan Zheng, Shuyu Gong, Jurong Yang   +4 more
doaj   +1 more source

Microscopic Polyangiitis Following mRNA COVID-19 Vaccination: A Case Report

Journal of Korean medical science, 2022
Coronavirus disease 2019 (COVID-19) is one of the most widespread viral infections in human history. As a breakthrough against infection, vaccines have been developed to achieve herd immunity.
Daeyoung So, K. Min, W. Jung, Sang-Woong Han, Mi-yeon Yu   +4 more
semanticscholar   +1 more source

Characterizing infection in anti-neutrophil cytoplasmic antibody-associated vasculitis:results from a longitudinal, matched-cohort data linkage study [PDF]

, 2020
Objectives: Infection exerts a major burden in ANCA-associated vasculitis (AAV), however, its precise extent and nature remains unclear. In this national study we aimed to longitudinally quantify, characterize and contextualize infection risk in AAV ...
Amft, Nicole, Basu, Neil, Black, Corri, Dhaun, Neeraj, Erwig, Lars, Harvie, John, Kumar, Vinod, Marks, Angharad, McGeoch, Lucy, McLaren, John, Sarica, Shifa H., Sznajd, Jan   +11 more
core   +6 more sources

Interstitial lung disease in microscopic polyangiitis and granulomatosis with polyangiitis: demographic, clinical, serological and radiological features of an Italian cohort from the Italian Society for Rheumatology.

Clinical and Experimental Rheumatology, 2022
OBJECTIVES Interstitial lung disease (ILD) has been described as a possible pulmonary involvement in antineutrophil cytoplasmic antibodies (ANCA)-associated vasculitides (AAV), mainly granulomatosis with polyangiitis (GPA) and microscopic polyangiitis ...
A. Manfredi, G. Cassone, R. Izzo, G. Dallagiacoma, M. Felicetti, A. Cariddi, A. Berti, A. Giollo, C. Nannini, S. Bettio, S. Monti, E. Conticini, M. Govoni, L. Quartuccio, L. Argolini, S. Kaleci, G. Emmi, C. Dejaco, R. Padoan, L. Dagna, M. Rossini, F. Cantini, C. Montecucco, B. Frediani, S. De Vita, R. Caporali, F. Muratore, M. Sebastiani, C. Salvarani   +28 more
semanticscholar   +1 more source

The role of the host—Neutrophil biology

Periodontology 2000, EarlyView., 2023
Abstract Neutrophilic polymorphonuclear leukocytes (neutrophils) are myeloid cells packed with lysosomal granules (hence also called granulocytes) that contain a formidable antimicrobial arsenal. They are terminally differentiated cells that play a critical role in acute and chronic inflammation, as well as in the resolution of inflammation and wound ...
Iain L. C. Chapple, Josefine Hirschfeld, Alpdogan Kantarci, Asaf Wilensky, Lior Shapira   +4 more
wiley   +1 more source

Relapsing subarachnoid hemorrhage as a clinical manifestation in microscopic polyangiitis: a case report and literature review

Clinical Rheumatology, 2022
Microscopic polyangiitis (MPA) is a systemic small-vessel vasculitis associated with anti-neutrophil cytoplasmic antibody (ANCA) and predominantly causes kidney and pulmonary injuries.
Jingjing Xie, Ertao Jia, Suli Wang, Ye-Hua Yu, Zhiling Li, Jianyong Zhang, Jia Li   +6 more
semanticscholar   +1 more source

Application of the 2022 ACR/EULAR criteria for microscopic polyangiitis to patients with previously diagnosed microscopic polyangiitis.

Clinical and Experimental Rheumatology, 2022
OBJECTIVES This study applied the 2022 American College of Rheumatology/European Alliance of Associations for Rheumatology (the 2022 ACR/EULAR) criteria for microscopic polyangiitis (MPA) to patients with previously diagnosed MPA as per the 2007 European
J. Pyo, S. Ahn, J. Song, Yong-Beom Park, Sang-Won Lee   +4 more
semanticscholar   +1 more source

Phase IIa Global Study Evaluating Rituximab for the Treatment of Pediatric Patients With Granulomatosis With Polyangiitis or Microscopic Polyangiitis

Arthritis & Rheumatology, 2021
To assess the safety, tolerability, pharmacokinetics, and efficacy of rituximab (RTX) in pediatric patients with granulomatosis with polyangiitis (GPA) or microscopic polyangiitis (MPA).
P. Brogan, R. Yeung, G. Cleary, S. Rangaraj, O. Kasapcopur, A. Hersh, Suzanne C. Li, D. Paripović, K. Schikler, A. Zeft, C. Bracaglia, D. Eleftheriou, P. Pordeli, S. Melega, C. Jamois, J. Gaudreault, M. Michalska, P. Brunetta, J. Cooper, P. Lehane   +19 more
semanticscholar   +1 more source

Rituximab Biosimilar Prevents Poor Outcomes of Microscopic Polyangiitis and Granulomatosis with Polyangiitis as Effectively as Rituximab Originator [PDF]

Yonsei medical journal, 2020
Purpose There has been no extensive study to compare the efficacy between rituximab originator (Mabthera®) and its biosimilar (Truxima®) for microscopic polyangiitis (MPA) and granulomatosis with polyangiitis (GPA).
Hyeok Chan Kwon, Minyoung Kevin Kim, Jason Jungsik Song, Yong‐Beom Park, Sang‐Won Lee   +4 more
openalex   +2 more sources